Chronic exposure to this competitive inhibitor of eNOS reduces NO formation and leads to vasoconstriction, endothelial dysfunction and hypertrophic vessels(45), which eventually results in sustained elevation of BP. The gene discussed is NOS3; the disease is endothelial dysfunction.